5
American Journal of Medical Genetics 27:959-963 (1987) Editorial Comment: Nager “Syndrome” Versus “Anomaly” and Its Nosology With the Postaxial Acrofacial Dysostosis Syndrome of Genee and Wiedemann John M. Opitz Department of Medical Genetics, Shodair Children’s Specialty Hospital, Helena, Montana; Departments of Pediatrics and Medicine (Medical Genetics), University of Washington, Seattle, Washington; Departments of Biology, History and Philosophy, Medicine (WAMI Program), and Veterinary Sciences, Montana State University, Bozeman, Montana; Departments of Medical Genetics and Pediatrics, University of Wisconsin, Madison. Wisconsin INTRODUCTION The preceding paper by Hecht and coworkers challenges our current understanding of the acrofacial dysostoses and begs the question whether the entity under discussion should be called a “syndrome” or an “anomaly” qua developmental field defect. It makes a difference. In genetic parlance, a syndrome is a causally defined, specific entity in which the component manifestations bear a pleiotropic relationship to each other. A developmental field defect (or anomaly) is a causally nonspecific entity in which the component manifestations bear a direct pathogenetic relationship to each other. The fetal alcohol syndrome (FAS) is causally defined on the basis of 1) a uniquely characteristic combination of functional and morphological manifestations, 2) history, 3) epidemiology, and 4) animal models. One manifestation-complex in the FAS may be the DiGeorge anomaly,” which is a causally highly heterogeneous polytopic developmental field defect, which may occur per se, and in the Zellweger syndrome, del(22qll) syndrome and other forms of aneuploidy, the bisdiamine and 1 3-cis-retinoic acid disruption sequences, etc. [ Lammer and Opitz, 19861. Received for publication January 7, 1987. Address reprint requests to Dr. John M. Opitz, Shodair Children’s Specialty Hospital, P.O. Box 5539, Helena, MT 59604. 0 1987 Alan R. Liss, Inc.

Nager “syndrome” versus “anomaly” and its nosology with the postaxial acrofacial dysostosis syndrome of Genée and Wiedemann

Embed Size (px)

Citation preview

Page 1: Nager “syndrome” versus “anomaly” and its nosology with the postaxial acrofacial dysostosis syndrome of Genée and Wiedemann

American Journal of Medical Genetics 27:959-963 (1987)

Editorial Comment: Nager “Syndrome” Versus “Anomaly” and Its Nosology With the Postaxial Acrofacial Dysostosis Syndrome of Genee and Wiedemann

John M. Opitz

Department of Medical Genetics, Shodair Children’s Specialty Hospital, Helena, Montana; Departments of Pediatrics and Medicine (Medical Genetics), University of Washington, Seattle, Washington; Departments of Biology, History and Philosophy, Medicine (WAMI Program), and Veterinary Sciences, Montana State University, Bozeman, Montana; Departments of Medical Genetics and Pediatrics, University of Wisconsin, Madison. Wisconsin

INTRODUCTION

The preceding paper by Hecht and coworkers challenges our current understanding of the acrofacial dysostoses and begs the question whether the entity under discussion should be called a “syndrome” or an “anomaly” qua developmental field defect.

It makes a difference. In genetic parlance, a syndrome is a causally defined, specific entity in which the

component manifestations bear a pleiotropic relationship to each other. A developmental field defect (or anomaly) is a causally nonspecific entity in which the component manifestations bear a direct pathogenetic relationship to each other. The fetal alcohol syndrome (FAS) is causally defined on the basis of 1 ) a uniquely characteristic combination of functional and morphological manifestations, 2) history, 3) epidemiology, and 4) animal models. One manifestation-complex in the FAS may be the DiGeorge anomaly,” which is a causally highly heterogeneous polytopic developmental field defect,

which may occur per se, and in the Zellweger syndrome, del(22qll) syndrome and other forms of aneuploidy, the bisdiamine and 1 3-cis-retinoic acid disruption sequences, etc. [ Lammer and Opitz, 19861.

Received for publication January 7, 1987.

Address reprint requests to Dr. John M. Opitz, Shodair Children’s Specialty Hospital, P.O. Box 5539, Helena, MT 59604.

0 1987 Alan R. Liss, Inc.

Page 2: Nager “syndrome” versus “anomaly” and its nosology with the postaxial acrofacial dysostosis syndrome of Genée and Wiedemann

960 Opitz

In a syndrome, none of the morphogenetic anomalies are obligatory in the sense that they are present in all cases and must be present before a diagnosis can be made; this is because of the rather indirect pathogenetic relationship between the component anomalies, especially in mosaic pleiotropy [Opitz et al, 19691. Because of the rather direct pathogenetic relationship between the parts of a developmental field (especially a monotopic field), impairment of one part is by definition almost always associated with (or leads to) visible defect in the other parts.

Syndromes are clinically studied in a process (syndrome delineation or phenotype analysis) that seeks to identify all actual and potential component manifestations, before and after birth, in both sexes and over the entire life-span of the affected individual by clinical and morphological methods. Because of the causally nonspecific and pathogeneti- cally limited nature of all of the component manifestations, the phenotypic spectrum of virtually every syndrome overlaps to some extent with that of others, identifying pathogenetic but not causal commonalities.

Syndromes are studied causally in a process (syndrome definition, genotype-r genetic-analysis) that seeks to identify the reason for the uniqueness of their overall phenotype through genealogical, segregational, cytogenetic, and biochemical methods that demonstrates etiologic homogeneity. The two methods are complementary and lead to the conclusion that cause of the phenotype is unique, but components of phenotype are not.

The study of developmental field defect works exactly in reverse to that of syndromes in the sense that one specific (primary or secondary) malformation, regardless of how complex, is studied with the aim to demonstrate its etiologic heterogeneity. Sometimes these studies are deliberate, occasionally the discovery of causal heterogeneity falls into one’s lap serendipitously. The prepared mind will seize hold of the observation joyfully and will pursue with grateful and humble disposition the developmental insights thus offered virtually gratis. The set mind with antipathy against the concept of fields, will, sometimes against better judgment, dismiss the data as irrelevant much as “primitive” peoples who seek separate explanations for lightning, thunder, and rain because they may be separated from each other by a moment of time (ie, may not be absolutely correlated).

NAGER SYNDROME VERSUS NAGER ANOMALY

How one wishes for the art of Verdi who went directly at the business of Rigoletto with only a few powerful chords to precede the first act, and his drive to create a major masterpiece of Western musical culture rather than a modest scholarly comment in only 40 days. But the matter brought up by Jacqueline Hecht and her coworkers is not easy, witness the entry of Dr. McKusick in the latest edition of his catalogs: “No. 15440: Mandibulofacial Dysostosis, Treacher Collins Type With Limb Anomalies (Nager Acrofacial Dysostosis, AFD, Nager Type).” It is not preceded by an asterisk, for the evidence for causal heterogeneity seems reasonably compelling. Hecht et al [ 19871 quote the recent paper by Reynolds et al [1986] who report on a previously apparently unreported autosomal dominant form of acrofacial dysostosis (AFD), which may repre- sent an iceberg (dominant) trait. The slightly modified Table I from the paper by Reynolds et al is reproduced here; the first entry in the Table is changed from “MFD with mild acral anomalies” to Reynolds-Webb syndrome, with appropriate reference citation. The word syndrome in the second entry has been put into quotation marks, for I think the time has come to change syndrome to “anomaly.”

Page 3: Nager “syndrome” versus “anomaly” and its nosology with the postaxial acrofacial dysostosis syndrome of Genée and Wiedemann

Acrofacial Dysostosis Anomaly 961

TABLE I. Conditions of Mandibulofacial Dysostosis with Acral Anomalies (The Acrofacial Dysostoses Broadly Speaking)*

Syndrome or association Cause Reference

Reynolds- Webb syndrome Nager “syndrome” Postaxial acrofacial

dysostosis syndrome (Genie- Wiedemann syndrome)

Fontaine syndrome Kelly syndrome Weyers syndrome

Townes-Brocks syndrome

AD AR, AD

Reynolds et al [ 19861 Halal et al [ 19831

AR

AD AR’? X-linked‘?

AD Roubicek and Spranger

AD

Miller et al [ 19791 Lewin and Opitz [ 19861 Fontaine et a1 [ 19741 Kelly et al [ 19771

[I9841 Kurnit et al [ 19781

Chromosome anomalies: distal 2q duplication Trisomy 18 Bersu and Ramirez-Castro

Trisomy 7 mosaicism Hodesetal [I9811

*Reprinted with some modifications by permission of Alan R. Liss, lnc. from Reynolds et a1 [1986].

Wagner and Cole [ 19791

[ 19771

The reasons for that change were explained previously [Opitz, 19861 and refer to apparent causal heterogeneity of acrofacial dysostosis (Nager) [Halal et al, 19831 and its suspected occurrence in a t least one instance of the Down syndrome. Since it seems likely that mandibulofacial dysostosis (MFD) represents a disturbance of neural crest action and/or development [Johnston and Sulik, 1979; Johnston et al, 19811 and since AFD does appear to be a polytopic developmental field, it follows that neural crest may indeed have something to do with limb development as postulated by McCredie [qv, North and McCredie, 19871. Recently, Sulik et a1 [ 19871 have postulated that MFD represents primary interference with first and second arch ectodermal placodal cells at a time when the neural crest cells are being released from the fusing neural folds.

NAGER ANOMALY VERSUS THE GENEE-WIEDEMANN SYNDROME

Figure 2 in the paper by Hecht et al [1987] possibly suggests slightly short 5th fingers; however, Figure 3 clearly shows bilateral abnormality of the most ulnar ray as well. On the right, the proximal portions of metacarpals 4 and 5 are fused (or never separated), and on the left the 5th metacarpal is represented by such a minute distal remnant that on radiologic examination the fetus appears to have only 3 metacarpals; the bones of both 5th digits are hypoplastic.

Does this mean that the fetuses observed by Hecht et al have the “postaxial acrofacial dysostosis syndrome” [Miller et al, 19791 ? Possibly, since in this misnamed condition affected individuals may also have radioulnar synostosis, preaxial involvement with hypoplastic or duplicated thumb(s), in addition to postaxial oligodactyly. However, absence of fibular involvement with polydactyly of toes speaks against the diagnosis in the fetuses studied by Hecht et al. Lewin and Opitz [ 19861 have suggested that this condition be called the GenCe-Wiedemann syndrome instead of postaxial acrofacial dysostosis syndrome. The observations in the syndrome of GenCe and Wiedemann and Reynolds and Webb suggest that acrofacial dysostosis need not be confined to pre- or postaxial involvement, but can involve both sides, as it does in the W T syndrome [Gonzalez et al, 19771.

Page 4: Nager “syndrome” versus “anomaly” and its nosology with the postaxial acrofacial dysostosis syndrome of Genée and Wiedemann

962 Opitz

All of the above notwithstanding, it is important to underscore one of the points made by Hecht et al-namely, given the birth of a fetus or child with AFD to a couple, a 25% recurrence risk must be considered and suggested in counseling unless examination of the parents documents in one of them evidence of AFD, which may be as mild as that reported by Reynolds et a1 [ 19861.

ACKNOWLEDGMENTS

This work was supported in part by a grant from the Montana State Department of Health and Environmental Sciences under HB430. I am most grateful to LaVelle M. Spano for expert secretarial collaboration.

REFERENCES

Bersu ET, Ramirez-Castro JL (1977): Anatomical analysis of the developmental effects of aneuploidy in man-the 1 X-trisomy syndrome: I. Anomalies of the head and neck. Am J Med Genet 1 : 173-193.

Fontaine G, Farriauz JP, Delattre P, Gidlecki 2, Poupard B, Durieux G, Piquet JJ (1974): Une observation familiale du syndrome ectrdactylie et dysostose mandibulo-faciale. J GCntt Hum 22:289-307.

Gonzalez CH, Durkin-Stamm MV, Gcimer NF. Shahidi NT, Schilling RF, Rubira F, Opitz J M (1977): Studies of malformation syndromes in man XLVI: The WT syndrome: A “new” autosomal dominant pleiotropic trait of radial/ulnar hypoplasia with high risk of bone marrow failure and/or leukemia. In Bergsma D. Lowry RB, Opitz J M (eds): “New Syndromes.” New York: Alan R. Liss, Inc., for the National Foundation-March of Dimes BD:OAS Xlll (3B):3 1-38.

Halal F. Herrmann J , Pallister PD, Opitz JM, Desgranges M-F, Grenier G (1983): Differential diagnosis of Nager acrofacial dysostosis syndrome: Report of four patients with Nager syndrome and discussion of other related syndromes. Am J Med Genet 14:209%224.

Hecht JT, Immken LL, Harris LF, Malini S, Scott CI J r (1987): The Nager syndrome. Am J Med Genet

Hod- ME, Gleiser S, DeRosa GP, Yune HY, G i r d DA, Weaver DD, Palmer CG (1981): Trisomy 7 mosaicism and manifestations of Goldenhar syndrome with unilateral radial hypoplasia. J Craniofac Genet Dev Biol 1 :49-55.

Johnston MC, Sulik KK (1979): Some abnormal patterns of development in the craniofacial region. In Melnick M, Jorgenson RJ (eds): “Developmental Aspects of Craniofacial Dysmorphology.” New York: Alan R. Liss, Inc., for the National Foundation-March of Dimes. BD:OAS XV(8):2342.

Johnston MC, Vig KWL, Ambrose LJH (1981): Neurocristopathy as a unifying concept: Clinical corrclations. In Riccardi VM, Mulvihill J J (eds): “Advances in Neurology: Neurofibromatosis (von Recklinghausen Disease).” New York: Raven Press 29:97-104.

Kelly TE. Cooke JR, Kesler RW (1977): Acrofacial dysostosis with growth and mental retardation i n three males, one with simultaneous Hermansky-Pudlak syndrome. In Bergsma D, Lowry RB, Opitr J M (eds): “New Syndromes.” New York: Alan R. Liss, Inc., for the National Foundation-March of Dimes. BD:OAS XI I I( 3B):45-52.

Kurnit DM, Steele MW, Pinsky L, Dibbins A (1978): Autosomal dominant transmission of a syndrome of anal, ear, renal and radial congenital malformations. J Pediatr 93:27&273.

Lammer EJ. Opitz J M (1986): The DiGeorge anomaly as a developmental field defect. Am J Med Genet Suppl 2:1 13-127.

Lewin SO, Opitz J&l (1986): Fibular a/hypoplasia: Review and documentation of the fibular developmental field. Am J Med Genet Suppl 2:215-238.

McKusick VA ( 1 986): “Mendelian Inheritance in Man. Catalogs of Autosomal Dominant, Autosomal Recessive and X-Linked Phenotypes,” 7th ed. Baltimore: Johns Hopkins University Press, p 477.

27:965-969.

Page 5: Nager “syndrome” versus “anomaly” and its nosology with the postaxial acrofacial dysostosis syndrome of Genée and Wiedemann

Acrofacial Dysostosis Anomaly 963

Miller M, Fineman R, Smith DW (1979): Postaxial acrofacial dysostosis syndrome. J Pediatr 95:97@975 North K, McCredie J (1987): Neurotomes and birth defects: A neuroanatomic method of interpretation of

multiple congenital malformations. Am J Med Genet Suppl 3 (in press). Opitz J M ( 1986): Editorial Comment: Developmental field theory and observations-accidental progress’? Am J

Med Genet Suppl 2:l-8. Opitz JM, Herrmann J, Dieker H (1969): The study of malformation syndromes in man. In Bergsma D (ed):

“The First Conference on the Clinical Delineation of Birth Defects Part 11. Malformation Syndromes.” The National Foundation-March of Dimes BD:OAS V(2):lLlO.

Reynolds JF. Webb MJ, Opitz JM (1986): A new autosomal dominant acrofacial dysostosis syndrome. Am J Med Genet Suppl 2:143-150.

Roubicek M, Spranger J (1984): Weyers acrodental dysostosis in a family. Clin Genet 26:587-590. Sulik KK, Johnston MC, Smiley SJ, Speight HS, Jarvis BE (1987): Mandibulofacial dysostosis (Treacher-

Wagner SF, Cole J (1979): Nager syndrome with partial duplication of the long arm of chromosome 2. Am J Collins Syndrome): A new proposal for its pathogenesis. Am J Med Genet 27:359-372.

Hum Genet 31(6):116A.

Edited by James F. Reynolds